NCT06023329

Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery

• Status: Suspended
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 36 (estimated)
• Sponsor: University of Minnesota · Academic / Other
• Sex: All
• Age: 3 Months – 18 Years
• Healthy volunteers: Not accepted

Summary

Literature on the use of superficial cervical plexus blocks for ear surgery is sparse in general, and almost non-existent in the pediatric population. Overall, literature review supports the safety of performance of this block but there is minimal published literature on its utility despite anecdotal evidence of benefit. This study, especially its prospective randomized nature will allow for expansion of the evidence for or against addition of this block to the care of pediatric patients undergoing ear surgery. The purpose of this study is to determine if SCPB plus standard practices provides superior pain control, as measured by reduced opiate consumption, compared to standard practices alone when performed on pediatric patients undergoing surgery on the ear and mastoid process.

Conditions

• Otolaryngologic Surgery

Interventions

Type	Name	Description
DRUG	ropivacaine	will receive SCPB with ropivacaine via regional anesthesia team
DRUG	Saline	will receive SCPB with saline via regional anesthesia team

Timeline

• Start date: 2023-01-03
• Primary completion: 2027-05-01
• Completion: 2027-05-01
• First posted: 2023-09-05
• Last updated: 2025-05-15

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study